Blog
911 Articles
Searching for Potential Pancreatic Cancer Blood Biomarkers
Researchers are using blood samples to follow people considered at risk for developing pancreatic cancer in a trial looking for early detection biomarkers.
Dousing Out-of-Control KRAS Signaling in Pancreatic Cancer
Rene Bernards and his team are targeting the signaling pathway of the KRAS mutation, which occurs in almost all pancreatic cancers.
Learning to Guide My Pancreatic Cancer Treatment
The more Colin Gabriel learned about pancreatic cancer, the more he realized he needed to guide his treatment, rather than go where his HMO recommended.
Harnessing the Power of Radionuclide Therapy
Julie Sutcliffe is working with targeted radionuclide therapy to go after pancreatic cancer cells that have spread beyond the pancreas.
A Second Opinion Leads to a New Treatment Plan
Brad Kerr changed his pancreatic cancer treatment plan after getting a second opinion, and had neoadjuvant chemotherapy before his Whipple.
Comparing Treatment Delivery Methods for Locally Advanced Pancreatic Cancer
A clinical trial compares intravenous chemotherapy delivery with intra-arterial chemotherapy to see which is more effective for pancreatic cancer.
Machine-Learning Assay May Improve Pancreatic Cyst Management
Dr. Anne Marie Lennon explains CompCyst, the artificial intelligence-based assay that can determine the best treatment for pancreatic cysts.
A Platinum Remembrance: The Power of Raising Your Voice
Gil Bashe and John Bianchi share a remembrance of Anne Glauber’s work and the power of advocacy on the eve of the Platinum PR Awards.
Pitching a Perfect Game Against Pancreatic Cancer
Andy Spiteri is a fantasy sports enthusiast, so he turned to his favorite activity to help him through pancreatic cancer treatment.
Pancreatic Cancer Pathology: How Doctors Get to a Diagnosis
Dr. Jingxin Qiu explains the role of pathology in grading a tumor and staging cancer, to help patients understand the pancreatic cancer diagnosis.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Kicking Pancreatic Cancer’s Butt
When Margie Goldsmith was diagnosed with an IPMN she made it her goal to beat that pancreatic cancer. It took two more tries but she did it.
Adding A Noninvasive Surgical Technique to Standard Treatment for Locally Advanced Pancreatic Cancer
A clinical trial compares standard treatment plus irreversible electroporation to standard treatment alone for locally advanced pancreatic cancer.
Platinum-Based Therapy Can Significantly Improve Survival for Some Pancreatic Cancer Patients
Dr. Michael Pishvaian explains how platinum-based therapy can improve the survival of pancreatic cancer patients with a specific mutation.
I’ll Never Stop Fighting
When Lynne Holcomb was diagnosed with stage IV pancreatic cancer, she kept fighting through treatment and made it onto a clinical trial.